Milena Georgieva has a PhD in Molecular Biology and is an Associate Professor at the Laboratory of Molecular Genetics, Institute of Molecular Biology, Bulgarian Academy of Sciences.
Currently Milena is involved in several projects which aim at studying the importance of higher-order levels of genome organization in the nucleus and their role in the regulation and maintenance of cellular and organismal fate. Her recent projects involve investigating the interplay between chromatin remodelling complexes and linker histones, which are important chromatin structural proteins that build and further maintain higher-order chromatin organization. This interaction proves to be crucial for normal cellular development at optimal and moreover under stress conditions. It also guides the process of ageing and is decisive for the progression of age-associated diseases.
Milena’s scientific career ranges beyond chromatin biology and encompasses projects in the field of biomedical sciences. Her research targets the molecular mechanisms of neurodegenerative diseases and cancer. It aims at the development of novel molecular markers for fast and precise diagnostics and, moreover, for the development of targeted therapies and personalized approaches for tackling disease at a molecular level.
She is a member of the editorial board of the Journal of Investigative Genomics and the Jupiter Online Journal of Case Studies. She is also a member of the Federation of the European Biochemical Societies and the Society of Clinical Epigenetics.
Milena has been presenting science at major national and international congresses and meetings for many years. She has co-authored more than 30 scientific publications and is the author of four book chapters focused on epigenetics and molecular biology.
She is often engaged in science communication. Her presentations target biological and socioeconomic problems like environmental pollution, and challenge the lack of adequate attitude toward food additives and genetically modified organisms. They also raise discussions for contemporary problems referring to recently increasing public concerns about the latest advances in modern technologies for genome editing and their application in real life.
Her research interests include epigenetics and epigenomics; cancer epigenetics and epigenetic differences between cells in norm and pathology; apoptosis and other types of cell death, molecular mechanisms and pathways; neuroscience and epigenetics of psychiatric disorders; biology and epigenetics of stem cells; and the biology of ageing and age-associated diseases.